8-K: Starry Sea SPAC Eyes China Health Firm Forever Young

Starry Sea Acquisition Corp. has signed a binding letter of intent for a proposed business combination with China-based health industry operator Forever Young International Limited.

Summary

• Starry Sea Acquisition Corp. (SSEA) entered into a binding Letter of Intent (LOI) with Forever Young International Limited for a proposed business combination.
• Forever Young is a Cayman Islands exempted company operating in the health industry, providing comprehensive management and support service solutions for medical institutions in China.
• The LOI establishes an exclusivity period for negotiating SSEA's acquisition of Forever Young, during which SSEA agreed not to solicit alternative business combination proposals.
• The pre-money equity value ascribed to Forever Young is contemplated to be in the range of approximately USD 750 million to USD 900 million, subject to confirmatory due diligence by both parties.
• The consideration for Forever Young's shareholders is expected to be comprised of rollover equity in the form of ordinary shares of the post-closing publicly-listed entity, each valued at $10 per share.
• The parties have agreed to a sixty (60) day period of mutual exclusivity, which may be automatically extended for one additional 45-day period under certain conditions.
• SSEA and Forever Young will use reasonable best efforts to negotiate and execute definitive agreements embodying the Proposed Transaction as soon as practicable.

Sentiment

Score: 7

Explanation: The signing of a binding Letter of Intent is a significant positive step for a SPAC, indicating concrete progress towards a de-SPAC transaction. The target company operates in a growing sector (China healthcare). However, it is still an LOI, subject to confirmatory due diligence, negotiation of definitive agreements, and standard risks associated with forward-looking statements.

Positives

• A binding Letter of Intent has been signed, representing a concrete step towards a de-SPAC transaction and indicating confidence in the proposed business combination.
• The target company, Forever Young, operates in the health industry in China, a sector with significant growth potential.
• The LOI includes an exclusivity period, providing a focused negotiation window for the parties.
• Management expresses excitement about the opportunity to help Forever Young scale to the next level with significant growth capital and SSEA's expertise in public markets.

Negatives

• The business combination is still subject to confirmatory due diligence by both parties and the negotiation and execution of definitive agreements.
• The contemplated pre-money equity valuation range of USD 750 million to USD 900 million for Forever Young is subject to change based on the outcome of due diligence.
• Forward-looking statements highlight various important factors that could cause actual results to differ materially, including the ability to enter into a definitive agreement and satisfy closing conditions.

Risks

• The ability of the parties to enter into a definitive agreement for the proposed business combination.
• The ability of the parties to satisfy the closing conditions required for the proposed transaction.
• Starry Sea Acquisition Corp.'s limited operating history as a blank check company.
• Competitive factors within Forever Young's industry and market in China.
• General economic conditions that could impact the business combination or the performance of the combined entity.
• Forward-looking statements are based on current expectations, assumptions, and projections which could be incorrect, and actual results may differ materially.

Future Outlook

The company anticipates negotiating and executing a definitive agreement for the proposed business combination with Forever Young. The objective is to help Forever Young scale to the next level with significant growth capital and SSEA's market expertise, aiming to bring a transformative business model to the larger marketplace.

Management Comments

• "We are super-excited about the opportunity to take you to the public markets."
• "You and your team have done an amazing job and we would like to help you scale to the next level with significant growth capital as well as our expertise in these markets."
• "We consider this a unique partnership opportunity where the SSEA team can help accelerate your teams plans and bring a transformative business model to the larger marketplace."

Industry Context

This announcement reflects the ongoing trend of Special Purpose Acquisition Companies (SPACs) identifying and merging with private companies to facilitate their public listing (de-SPAC transaction). Forever Young operates in the China health industry, a sector experiencing significant growth driven by an aging population, rising incomes, and increasing demand for quality healthcare services. The proposed combination aims to leverage SSEA's public market access and capital to support Forever Young's expansion within this dynamic market, aligning with broader industry consolidation and international investment trends in healthcare.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders of Starry Sea Acquisition Corp. face potential value creation from a successful business combination, but also risks related to the target company's performance and transaction execution. They will be required to vote on the proposed transaction.
• Shareholders of Forever Young International Limited will receive rollover equity in the combined public entity, gaining access to public markets and liquidity.
• Employees of Forever Young International Limited may experience growth opportunities and potential expansion as the company scales with new capital and public market access.
• Customers of Forever Young International Limited could benefit from improved services and expanded offerings resulting from increased capital and operational support.

Next Steps

• Negotiate and execute definitive agreements embodying the proposed business combination as soon as practicable.
• Conduct confirmatory due diligence by both Starry Sea Acquisition Corp. and Forever Young International Limited.
• If a definitive agreement is entered into, Starry Sea Acquisition Corp. will prepare and file a proxy statement with the SEC, to be mailed to its stockholders.
• Starry Sea Acquisition Corp. stockholders will be urged to read the proxy statement and other relevant documents, and will ultimately vote on the approval of the proposed transaction and related matters.

Key Dates

Recommendation

While the binding Letter of Intent is a positive and necessary step for Starry Sea Acquisition Corp., it represents an early stage in the de-SPAC process. The proposed business combination is subject to extensive due diligence, negotiation of definitive agreements, and shareholder approval. The valuation range is broad, and the ultimate terms are not yet finalized. Investors should hold their position and await further details, including the definitive agreement and proxy statement, to assess the full financial and strategic implications before making a more definitive investment decision. The China healthcare market offers growth potential, but also carries specific regulatory and market risks that warrant careful consideration.

Keywords

SPAC, Business Combination, Merger, Healthcare, China, Medical Services, Starry Sea Acquisition Corp., Forever Young International Limited, LOI, De-SPAC, NASDAQ